microdosing glp-1 receptor agonists THE PCCA BLOG Thinking About Microdosing GLP-1? 5

Even among those who are prescribed treatment, only about half take the medication beyond one year

15,20 Although many of these AEs have occurred early in therapy and subsided over time, they remain a primary reason for dose adjustment or discontinuation

doi: 10.1056/NEJMoa1411892 44 WildingJPHBatterhamRLCalannaSDaviesMVan GaalLFLingvayIet al

ESM Figs 1 and 2 shows that calendar year of drug initiation had little effect on the cumulative incidence of treatment discontinuation for both study drugs

Because GLP-1 pricing now varies by drug, dose, formulation, and whether a patient is in an introductory or maintenance phase, its helpful to consider a range of current prices